Comparison of plasma responses human subjects after the ingestion of 3R,3R′-zeaxanthin dipalmitate from wolfberry (Lycium barbarum) and non-esterified 3R,3R′-zeaxanthin using chiral high-performance liquid chromatography

Zur Kurzanzeige

dc.identifier.uri http://dx.doi.org/10.15488/2667
dc.identifier.uri http://www.repo.uni-hannover.de/handle/123456789/2693
dc.contributor.author Breithaupt, Dietmar E.
dc.contributor.author Weller, Philipp
dc.contributor.author Wolters, Maike
dc.contributor.author Hahn, Andreas
dc.date.accessioned 2018-01-29T12:30:32Z
dc.date.available 2018-01-29T12:30:32Z
dc.date.issued 2004
dc.identifier.citation Breithaupt, D.E.; Weller, P.; Wolters, M.; Hahn, A.: Comparison of plasma responses human subjects after the ingestion of 3R,3R′-zeaxanthin dipalmitate from wolfberry (Lycium barbarum) and non-esterified 3R,3R′-zeaxanthin using chiral high-performance liquid chromatography. In: British Journal of Nutrition 91 (2004), Nr. 5, S. 707-713. DOI: https://doi.org/10.1079/BJN20041105
dc.description.abstract Age-related macular degeneration (AMD) is one of the most common eye diseases of elderly individuals. It has been suggested that lutein and zeaxanthin may reduce the risk for AMD. Information concerning the absorption of non-esterified or esterified zeaxanthin is rather scarce. Furthermore, the formation pathway of meso (3R,3′S)-zeaxanthin, which does not occur in plants but is found in the macula, has not yet been identified. Thus, the present study was designed to assess the concentration of 3R,3R′-zeaxanthin reached in plasma after the consumption of a single dose of native 3R,3′R-zeaxanthin palmitate from wolfberry (Lycium barbarum) or non-esterified 3R,3′ R-zeaxanthin in equal amounts. In a randomised, single-blind cross-over study, twelve volunteers were administered non-esterified or esterified 3R,3′R-zeaxanthin (5 mg) suspended in yoghurt together with a balanced breakfast. Between the two intervention days, a 3-week depletion period was inserted. After fasting oven-tight, blood was collected before the dose (0 h), and at 3, 6, 9, 12, and 24 h after the dose. The concentration of non-esterified 3R,3′R-zeaxanthin was determined by chiral HPLC. For the first time, chiral liquid chromatography-atmospheric pressure chemical ionisation-MS was used to confirm the appearance of 3R,3′R-zeaxanthin in pooled plasma samples. Independent of the consumed diet, plasma 3R,3′ R-zeaxanthin concentrations increased significantly (P=0.05) and peaked after 9-24 h. Although the concentration curves were not distinguishable, the respective areas under the curve were distinguishable according to a two-sided F and t test (P=0.05). Thus, the study indicates an enhanced bioavailability of 3R,3′ R-zeaxanthin dipalmitate compared with the non-esterified form. The formation of meso-zeaxanthin was not observed during the time period studied. © The Authors 2004. eng
dc.language.iso eng
dc.publisher Cambridge : Cambridge University Press
dc.relation.ispartofseries British Journal of Nutrition 91 (2004), Nr. 5
dc.rights Es gilt deutsches Urheberrecht. Das Dokument darf zum eigenen Gebrauch kostenfrei genutzt, aber nicht im Internet bereitgestellt oder an Außenstehende weitergegeben werden. Dieser Beitrag ist aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.
dc.subject 3R,3′R-zeaxanthin eng
dc.subject Chiral analysis eng
dc.subject Liquid chromatography-atmospheric pressure chemical ionisation-mass spectrometry eng
dc.subject Plasma carotenoid response eng
dc.subject Zeaxanthin esters eng
dc.subject antilipemic agent eng
dc.subject contraceptive agent eng
dc.subject ester eng
dc.subject laxative eng
dc.subject Lycium barbarum extract eng
dc.subject plant extract eng
dc.subject unclassified drug eng
dc.subject yoghurt eng
dc.subject zeaxanthin eng
dc.subject zeaxanthin dipalmitate eng
dc.subject area under the curve eng
dc.subject article eng
dc.subject blood sampling eng
dc.subject chirality eng
dc.subject clinical trial eng
dc.subject controlled clinical trial eng
dc.subject controlled study eng
dc.subject crossover procedure eng
dc.subject diet restriction eng
dc.subject drug absorption eng
dc.subject drug bioavailability eng
dc.subject drug blood level eng
dc.subject esterification eng
dc.subject female eng
dc.subject food intake eng
dc.subject high performance liquid chromatography eng
dc.subject human eng
dc.subject human experiment eng
dc.subject ingestion eng
dc.subject liquid chromatography eng
dc.subject Lycium eng
dc.subject Lycium barbarum eng
dc.subject male eng
dc.subject mass spectrometry eng
dc.subject meal eng
dc.subject randomized controlled trial eng
dc.subject single blind procedure eng
dc.subject statistical significance eng
dc.subject Student t test eng
dc.subject suspension eng
dc.subject volunteer eng
dc.subject Adult eng
dc.subject beta Carotene eng
dc.subject Chromatography, High Pressure Liquid eng
dc.subject Cross-Over Studies eng
dc.subject Dietary Supplements eng
dc.subject Female eng
dc.subject Humans eng
dc.subject Lycium eng
dc.subject Male eng
dc.subject Mass Spectrometry eng
dc.subject Palmitates eng
dc.subject Plant Extracts eng
dc.subject Single-Blind Method eng
dc.subject Stereoisomerism eng
dc.subject Xanthophylls eng
dc.subject Lycium eng
dc.subject Lycium barbarum eng
dc.subject.ddc 610 | Medizin, Gesundheit ger
dc.title Comparison of plasma responses human subjects after the ingestion of 3R,3R′-zeaxanthin dipalmitate from wolfberry (Lycium barbarum) and non-esterified 3R,3R′-zeaxanthin using chiral high-performance liquid chromatography eng
dc.type Article
dc.type Text
dc.relation.issn 0007-1145
dc.relation.doi https://doi.org/10.1079/BJN20041105
dc.bibliographicCitation.issue 5
dc.bibliographicCitation.volume 91
dc.bibliographicCitation.firstPage 707
dc.bibliographicCitation.lastPage 713
dc.description.version publishedVersion
tib.accessRights frei zug�nglich


Die Publikation erscheint in Sammlung(en):

Zur Kurzanzeige

 

Suche im Repositorium


Durchblättern

Mein Nutzer/innenkonto

Nutzungsstatistiken